Alexei Lukashev, Ph.D.
Stemedica International’s General Manager
europe meds online buy cialis go to site go site source https://theoregoncabaret.com/buy-paper-mache-paste/ source clomid for fertility when fail to reject null hypothesis link sentences essay writing quels sont les generiques du viagra viagra permanent side effects watch source thesis statement breast cancer http://www.salganyc.org/2580-viagra-sales-uk/ http://flahertyseminar.org/graduate/sqa-national-5-english-specimen-paper/28/ how to order viagra online see url enter source link do you have to be in the mood for viagra to work click here http://www.chesszone.org/lib/order-of-operations-essay-2998.html help with english homework online best site to buy viagra forum proofreading images cials on line sale see url http://www.wellchild.org/ed-professional-viagra/ Dr. Alexei Lukashev joined Stemedica Cell Technologies Inc. in 2007 as director of laser stem cell technologies before being promoted to general manager of its subsidiary Stemedica International in 2013. In 2011 he initiated pre-clinical stem cell research at Switzerland’s Ecole Polytechnique Fédérale de Lausanne (EPFL). Subsequently, he was instrumental in securing a three-year grant from the Swiss Commission for Technology and Innovation (CTI) for an EPFL and Stemedica International joint project on Alzheimer imaging (AIM) and stem cell therapies. Before joining Stemedica he held research and product-development positions at Thermotrex, Trex Enterprises and Cymer, including developing lasers for hair removal, vascular treatment and skin resurfacing. Dr. Lukashev currently holds seven U.S. patents and has been published in more than 40 peer reviewed journals and conference proceedings. He is a member of SPIE and ASLMS. He studied under Nobel Prize Winner and Academician Alexander Prokhorov at Moscow’s General Physics Institute (GPI), where Lukashev earned his Ph.D. in laser physics in 1992.